Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement

[1]  Richard B Thompson,et al.  Saturation recovery single‐shot acquisition (SASHA) for myocardial T1 mapping , 2014, Magnetic resonance in medicine.

[2]  L. Kuller,et al.  Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. , 2014, European heart journal.

[3]  Stefan Neubauer,et al.  T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. , 2013, JACC. Cardiovascular imaging.

[4]  Stefan Neubauer,et al.  T1 measurements in the human myocardium: The effects of magnetization transfer on the SASHA and MOLLI sequences , 2013, Magnetic resonance in medicine.

[5]  M. Robson,et al.  T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. , 2013, JACC. Cardiovascular imaging.

[6]  E. Goodman,et al.  Myocardial Tissue Remodeling in Adolescent Obesity , 2013, Journal of the American Heart Association.

[7]  Peter Kellman,et al.  Influence of Off-resonance in myocardial T1-mapping using SSFP based MOLLI method , 2013, Journal of Cardiovascular Magnetic Resonance.

[8]  P. Kellman,et al.  T1 and extracellular volume mapping in the heart: estimation of error maps and the influence of noise on precision , 2013, Journal of Cardiovascular Magnetic Resonance.

[9]  Richard B. Thompson,et al.  Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling , 2013, Journal of Cardiovascular Magnetic Resonance.

[10]  Andrew S Flett,et al.  Comprehensive Validation of Cardiovascular Magnetic Resonance Techniques for the Assessment of Myocardial Extracellular Volume , 2013, Circulation. Cardiovascular imaging.

[11]  S. K. White,et al.  Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping , 2013, Circulation. Cardiovascular imaging.

[12]  M. Gheorghiade,et al.  Strategies and opportunities for drug development in heart failure. , 2013, JAMA.

[13]  M. Robson,et al.  Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. , 2013, JACC. Cardiovascular imaging.

[14]  Tevfik F Ismail,et al.  Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. , 2013, JAMA.

[15]  E. Nagel,et al.  Native Myocardial T1 Mapping by Cardiovascular Magnetic Resonance Imaging in Subclinical Cardiomyopathy in Patients With Systemic Lupus Erythematosus , 2013, Circulation. Cardiovascular imaging.

[16]  M. Friedberg,et al.  Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy , 2013, Journal of Cardiovascular Magnetic Resonance.

[17]  Andrew S Flett,et al.  Human non-contrast T1 values and correlation with histology in diffuse fibrosis , 2013, Heart.

[18]  S. K. White,et al.  Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI , 2013, Journal of Cardiovascular Magnetic Resonance.

[19]  P. Kellman,et al.  Effectiveness of late gadolinium enhancement to improve outcomes prediction in patients referred for cardiovascular magnetic resonance after echocardiography , 2013, Journal of Cardiovascular Magnetic Resonance.

[20]  R. Kwong,et al.  Role of Transcytolemmal Water-Exchange in Magnetic Resonance Measurements of Diffuse Myocardial Fibrosis in Hypertensive Heart Disease , 2013, Circulation. Cardiovascular imaging.

[21]  A. Flett,et al.  Quantification of Myocardial Extracellular Volume Fraction in Systemic AL Amyloidosis: An Equilibrium Contrast Cardiovascular Magnetic Resonance Study , 2013, Circulation. Cardiovascular imaging.

[22]  Andrew S Flett,et al.  Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR , 2012, Journal of Cardiovascular Magnetic Resonance.

[23]  James O. Mudd,et al.  T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. , 2012, Radiology.

[24]  A. Taylor,et al.  Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study. , 2012, European heart journal cardiovascular Imaging.

[25]  Peter Kellman,et al.  Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience , 2012, Journal of Cardiovascular Magnetic Resonance.

[26]  Peter Kellman,et al.  Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method , 2012, Journal of Cardiovascular Magnetic Resonance.

[27]  V. Gudnason,et al.  Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. , 2012, JAMA.

[28]  P. Kellman,et al.  Association Between Extracellular Matrix Expansion Quantified by Cardiovascular Magnetic Resonance and Short-Term Mortality , 2012, Circulation.

[29]  R. Falk,et al.  Quantification of extracellular matrix expansion by CMR in infiltrative heart disease. , 2012, JACC. Cardiovascular imaging.

[30]  Jianhua Yao,et al.  Interstitial myocardial fibrosis assessed as extracellular volume fraction with low-radiation-dose cardiac CT. , 2012, Radiology.

[31]  A. Taylor,et al.  Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease , 2012, Heart.

[32]  Steffen Ringgaard,et al.  Assessment of intramyocardial hemorrhage by T1-weighted cardiovascular magnetic resonance in reperfused acute myocardial infarction , 2012, Journal of Cardiovascular Magnetic Resonance.

[33]  T. Wynn,et al.  Mechanisms of fibrosis: therapeutic translation for fibrotic disease , 2012, Nature Medicine.

[34]  M. Robson,et al.  Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance , 2012, Journal of Cardiovascular Magnetic Resonance.

[35]  A. Uy‐Evanado,et al.  Vulnerable Myocardial Interstitium in Patients With Isolated Left Ventricular Hypertrophy and Sudden Cardiac Death: A Postmortem Histological Evaluation , 2012, Journal of the American Heart Association.

[36]  P. Kellman,et al.  Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. , 2012, JACC. Cardiovascular imaging.

[37]  P. Kellman,et al.  Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. , 2012, European heart journal.

[38]  David A Bluemke,et al.  T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA , 2012, Journal of Cardiovascular Magnetic Resonance.

[39]  M. Robson,et al.  Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction , 2012, Journal of Cardiovascular Magnetic Resonance.

[40]  Richard D. White,et al.  Prognostic Value of Routine Cardiac Magnetic Resonance Assessment of Left Ventricular Ejection Fraction and Myocardial Damage: An International, Multicenter Study , 2011, Circulation. Cardiovascular imaging.

[41]  Andrew S Flett,et al.  Novel imaging techniques for diffuse myocardial fibrosis. , 2011, Future cardiology.

[42]  L. Lerman,et al.  Reversal of experimental renovascular hypertension restores coronary microvascular function and architecture. , 2011, American journal of hypertension.

[43]  P. Kellman,et al.  Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus , 2011, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[44]  R. Kwong,et al.  Measuring myocardial scar by CMR. , 2011, JACC. Cardiovascular imaging.

[45]  Vivek Muthurangu,et al.  Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. , 2011, JACC. Cardiovascular imaging.

[46]  E. Ritz,et al.  High-Dose Enalapril Treatment Reverses Myocardial Fibrosis in Experimental Uremic Cardiomyopathy , 2011, PloS one.

[47]  Stefan Neubauer,et al.  Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[48]  Michael Jerosch-Herold,et al.  Quantification of Diffuse Myocardial Fibrosis and Its Association With Myocardial Dysfunction in Congenital Heart Disease , 2010, Circulation. Cardiovascular imaging.

[49]  G. Schuler,et al.  Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers. , 2010, European heart journal.

[50]  M. Hayward,et al.  Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans , 2010, Circulation.

[51]  S. Heymans,et al.  Replacement and reactive myocardial fibrosis in idiopathic dilated cardiomyopathy: comparison of magnetic resonance imaging with right ventricular biopsy , 2010, European journal of heart failure.

[52]  R. Muthupillai,et al.  Prognostic Significance of Delayed-Enhancement Magnetic Resonance Imaging: Survival of 857 Patients With and Without Left Ventricular Dysfunction , 2009, Circulation.

[53]  A. Heagerty,et al.  Diabetic cardiomyopathy--a distinct disease? , 2009, Best practice & research. Clinical endocrinology & metabolism.

[54]  Sandeep N. Gupta,et al.  Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. , 2008, Journal of the American College of Cardiology.

[55]  Michael Jerosch-Herold,et al.  Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. , 2008, American journal of physiology. Heart and circulatory physiology.

[56]  Andreas Greiser,et al.  Optimization and validation of a fully‐integrated pulse sequence for modified look‐locker inversion‐recovery (MOLLI) T1 mapping of the heart , 2007, Journal of magnetic resonance imaging : JMRI.

[57]  M. Andrassy,et al.  Cardiac Troponin I but Not Cardiac Troponin T Induces Severe Autoimmune Inflammation in the Myocardium , 2006, Circulation.

[58]  David M Higgins,et al.  Human myocardium: single-breath-hold MR T1 mapping with high spatial resolution--reproducibility study. , 2006, Radiology.

[59]  F. Villarreal,et al.  The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[60]  T. Kato,et al.  Mineralocorticoid Receptor Antagonism Ameliorates Left Ventricular Diastolic Dysfunction and Myocardial Fibrosis in Mildly Symptomatic Patients With Idiopathic Dilated Cardiomyopathy: A Pilot Study , 2005, Circulation.

[61]  R. Kim,et al.  Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. , 2005, European heart journal.

[62]  Peter Hunold,et al.  Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. , 2005, AJR. American journal of roentgenology.

[63]  Michael Markl,et al.  On flow effects in balanced steady‐state free precession imaging: Pictorial description, parameter dependence, and clinical implications , 2004, Journal of magnetic resonance imaging : JMRI.

[64]  Rong Zhou,et al.  Simultaneous measurement of arterial input function and tumor pharmacokinetics in mice by dynamic contrast enhanced imaging: Effects of transcytolemmal water exchange , 2004, Magnetic resonance in medicine.

[65]  David M Higgins,et al.  Modified Look‐Locker inversion recovery (MOLLI) for high‐resolution T1 mapping of the heart , 2004, Magnetic resonance in medicine.

[66]  David Moher,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. , 2004, Family practice.

[67]  E. Boerwinkle,et al.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. , 2003, Circulation.

[68]  D. Rennie,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative , 2003, BMJ : British Medical Journal.

[69]  Arantxa González,et al.  Losartan-Dependent Regression of Myocardial Fibrosis Is Associated With Reduction of Left Ventricular Chamber Stiffness in Hypertensive Patients , 2002, Circulation.

[70]  Ruben Coronel,et al.  Activation Delay After Premature Stimulation in Chronically Diseased Human Myocardium Relates to the Architecture of Interstitial Fibrosis , 2001, Circulation.

[71]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[72]  C. Brilla,et al.  Lisinopril-Mediated Regression of Myocardial Fibrosis in Patients With Hypertensive Heart Disease , 2000, Circulation.

[73]  B. Strauer,et al.  Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease. , 2000, Hypertension.

[74]  Xin Li,et al.  Equilibrium transcytolemmal water‐exchange kinetics in skeletal muscle in vivo , 1999, Magnetic resonance in medicine.

[75]  C. Higgins,et al.  Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. , 1999, Radiology.

[76]  C. Roffe.  Ageing of the heart. , 1998, British journal of biomedical science.

[77]  P R Ershler,et al.  Myocardial electrical propagation in patients with idiopathic dilated cardiomyopathy. , 1993, The Journal of clinical investigation.

[78]  K. Weber,et al.  Pathological Hypertrophy and Cardiac Interstitium: Fibrosis and Renin‐Angiotensin‐Aldosterone System , 1991, Circulation.

[79]  H. Dargie,et al.  Ventricular arrhythmias in hypertensive left ventricular hypertrophy. Relationship to coronary artery disease, left ventricular dysfunction, and myocardial fibrosis. , 1990, American journal of hypertension.

[80]  S. Factor,et al.  A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. , 1990, Circulation.

[81]  K. R. Anderson,et al.  Histopathological types of cardiac fibrosis in myocardial disease , 1979, The Journal of pathology.

[82]  A. Brading,et al.  Distribution and kinetics of CoEDTA in smooth muscle, and its use as an extracellular marker , 1969, The Journal of physiology.

[83]  J. Schulz-Menger,et al.  T1 mapping in patients with acute myocardial infarction. , 2003, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[84]  B. Swynghedauw,et al.  Molecular mechanisms of myocardial remodeling. , 1999, Physiological reviews.

[85]  E. Sonnenblick,et al.  The cellular basis of dilated cardiomyopathy in humans. , 1995, Journal of molecular and cellular cardiology.

[86]  C A Beltrami,et al.  Structural basis of end-stage failure in ischemic cardiomyopathy in humans. , 1994, Circulation.

[87]  S. Fleagle,et al.  Effect of tissue fat and water content on nuclear magnetic resonance relaxation times of cardiac and skeletal muscle. , 1990, Magnetic resonance imaging.